Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BFLY
SELLButterfly Network, Inc. · Healthcare · United States · $1.7B · Avg Vol: $72M/d
COMPANY DESCRIPTION
Butterfly Network, Inc. is a digital health company that developed the Butterfly iQ, the world's first handheld, single-probe whole-body ultrasound system. The company's competitive moat is its proprietary Ultrasound-on-a-Chip technology, which democratizes medical imaging by reducing costs and increasing portability. It operates as a disruptive medical device player targeting the global point-of-care imaging market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 73.4M | 65.9M | 82.1M | 97.6M | 10.0% | 102.9M | 118.8M | 142.2M | 20.7% |
| EPS | -0.84 | -0.65 | -0.34 | -0.31 | — | -0.30 | — | — | — |
| Shares | 200.9M | 207.6M | 215.1M | 253.7M | +26.3% | 235.2M | — | — | — |
| Debt | 31.9M | 25.0M | 22.8M | 20.4M | -13.8% | 19.8M | — | — | — |
| Equity | 325.4M | 220.1M | 168.8M | 196.0M | -15.5% | — | — | — | — |
| Op CF | -169.1M | -98.8M | -41.7M | -12.7M | — | -14.9M | — | — | — |
| Inv CF | -93.8M | 70.4M | -2.7M | -3.3M | — | — | — | — | — |
| Fin CF | 2.9M | 0.2M | -1.5M | 77.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BFLY are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BFLY | Butterfly Network, Inc.(you) | $1.7B | 34 | SELL |
| NEOG | Neogen Corporation | $2.0B | 37 | HOLD |
| TMDX | TransMedics Group, Inc. | $2.5B | 34 | SELL |
| ESTA | Establishment Labs Holdings Inc. | $2.7B | 36 | HOLD |
| ATEC | Alphatec Holdings, Inc. | $1.3B | 27 | SELL |
| TNDM | Tandem Diabetes Care, Inc. | $1.2B | 25 | SELL |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.1B | 26 | SELL |
| IRTC | iRhythm Holdings, Inc. | $3.6B | 30 | SELL |
| AORT | Artivion, Inc. | $1.2B | 22 | SELL |
| QDEL | QuidelOrtho Corporation | $1.1B | 47 | HOLD |
Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.5%